Chris Compton

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 30

Top Topics

Chronic Obstructive Pulmonary Disease

Top Venues

International journal of chronic obstructive pulmonary disease

Respiratory research

BMJ open respiratory research

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Kieran J Rothnie, Robert P Wood, Alexandrosz Czira, Victoria L Banks, Lucinda J Camidge, Olivia K I Massey, Monica Seif, Chris Compton, Raj Sharma, David M G Halpin, Afisi S Ismaila, Claus F Vogelmeier
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study. BMJ open respiratory research 11 (1) (2024)
Claus F Vogelmeier, Kai-Michael Beeh, Michael Schultze, Nils Kossack, Lena M Richter, Jing Claussen, Chris Compton, Stephen G Noorduyn, Afisi S Ismaila, Gema Requena
Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study. International journal of chronic obstructive pulmonary disease 19 (2024)
Claus F Vogelmeier, Kai-Michael Beeh, Michael Schultze, Nils Kossack, Lena M Richter, Jing Claussen, Chris Compton, Stephen G Noorduyn, Afisi S Ismaila, Gema Requena
Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study. International journal of chronic obstructive pulmonary disease 19 (2024)
Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fraence Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International journal of chronic obstructive pulmonary disease 19 (2024)
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fraence Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International journal of chronic obstructive pulmonary disease 19 (2024)
Afisi S Ismaila, Kieran J Rothnie, Robert P Wood, Victoria L Banks, Lucinda J Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N Millard, Olivia Massey, David M G Halpin
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respiratory research 25 (1) (2024)
Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fraence Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International journal of chronic obstructive pulmonary disease 19 (2024)
Kieran J Rothnie, Robert P Wood, Alexandrosz Czira, Victoria L Banks, Lucinda J Camidge, Olivia K I Massey, Monica Seif, Chris Compton, Raj Sharma, David M G Halpin, Afisi S Ismaila, Claus F Vogelmeier
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study. BMJ open respiratory research 11 (1) (2024)
Afisi S Ismaila, Kieran J Rothnie, Robert P Wood, Victoria L Banks, Lucinda J Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N Millard, Olivia Massey, David M G Halpin
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respiratory research 25 (1) (2024)
Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Kieran J Rothnie, Robert P Wood, Alexandrosz Czira, Victoria L Banks, Lucinda J Camidge, Olivia K I Massey, Monica Seif, Chris Compton, Raj Sharma, David M G Halpin, Afisi S Ismaila, Claus F Vogelmeier
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study. BMJ open respiratory research 11 (1) (2024)
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fraence Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International journal of chronic obstructive pulmonary disease 19 (2024)
Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Robyn Kendall, Alan A Martin, Dhvani Shah, Soham Shukla, Chris Compton, Afisi S Ismaila
Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK. International journal of chronic obstructive pulmonary disease 18 (2023)
Kieran J Rothnie, Beade Numbere, Steven Gelwicks, Yifei Lu, Raj Sharma, Chris Compton, Afisi S Ismaila, Jennifer Kathleen Quint
Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK. International journal of chronic obstructive pulmonary disease 18 (2023)
Alexandrosz Czira, Sneha Purushotham, Ike Iheanacho, Kieran J Rothnie, Chris Compton, Afisi S Ismaila
Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review. International journal of chronic obstructive pulmonary disease 18 (2023)
Alexandrosz Czira, Gema Requena, Victoria L Banks, Robert P Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie A C Wild, Chris Compton, Kieran J Rothnie, Felix J F Herth, Jennifer Kathleen Quint, Afisi S Ismaila
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β 2 -Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Gema Requena, Alexandrosz Czira, Victoria L Banks, Robert P Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie A C Wild, Chris Compton, Kieran J Rothnie, Felix J F Herth, Jennifer Kathleen Quint, Afisi S Ismaila
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Gema Requena, Alexandrosz Czira, Victoria L Banks, Robert P Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie A C Wild, Chris Compton, Kieran J Rothnie, Felix J F Herth, Jennifer Kathleen Quint, Afisi S Ismaila
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Gema Requena, Victoria L Banks, Alexandrosz Czira, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β 2 -Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Alexandrosz Czira, Sneha Purushotham, Ike Iheanacho, Kieran J Rothnie, Chris Compton, Afisi S Ismaila
Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review. International journal of chronic obstructive pulmonary disease 18 (2023)
Alexandrosz Czira, Gema Requena, Victoria L Banks, Robert P Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie A C Wild, Chris Compton, Kieran J Rothnie, Felix J F Herth, Jennifer Kathleen Quint, Afisi S Ismaila
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β 2 -Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Gema Requena, Victoria L Banks, Alexandrosz Czira, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β 2 -Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Afisi S Ismaila, Kieran J Rothnie, Robert P Wood, Victoria L Banks, Lucinda J Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N Millard, Olivia Massey, David M G Halpin
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respiratory research 24 (1) (2023)
David M G Halpin, Robyn Kendall, Soham Shukla, Alan A Martin, Dhvani Shah, Dawn Midwinter, Kai-Michael Beeh, Janwillem W H Kocks, Paul W Jones, Chris Compton, Nancy A Risebrough, Afisi S Ismaila
Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Afisi S Ismaila, Katrin Haeussler, Alexandrosz Czira, Ji-Hee Youn, Mia Malmenas, Nancy A Risebrough, Jatin Agarwal, Maria Nassim, Raj Sharma, Chris Compton, Claus F Vogelmeier, Meilan K Han, David M G Halpin
Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis. Advances in therapy 39 (9) (2022)
David M G Halpin, Kieran J Rothnie, Victoria L Banks, Alexandrosz Czira, Chris Compton, Robert P Wood, Theo Tritton, Olivia Massey, Rosie A C Wild, Neil G Snowise, Kirill Nikitin, Raj Sharma, Afisi S Ismaila, Claus F Vogelmeier
Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. International journal of chronic obstructive pulmonary disease 17 (2022)